Nov 14, 2022 / 09:30PM GMT
Operator
Good day and welcome to the ENDRA Life Sciences third-quarter 2022 financial results conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Ms. Yvonne Briggs. Please go ahead.
Yvonne Briggs - LHA - IR
Thank you, operator. This is Yvonne Briggs with LHA. Good afternoon and welcome to ENDRA's third-quarter 2022 business update and financial results conference call. Earlier today, ENDRA issued a press release on this topic, which is available in the Investors section of ENDRA's website.
Before we begin, please note that today's discussion will include forward-looking statements. All statements by management, other than statements of historical facts, including statements regarding the company's strategies, financial condition, operations, costs, plans, and objectives, as well as the anticipated results of development and commercialization efforts, the timing of clinical studies, potential partnership opportunities, and expectations regarding regulatory processes, receipt
Q3 2022 ENDRA Life Sciences Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
